Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.00
Bid: 296.00
Ask: 304.00
Change: -4.00 (-1.33%)
Spread: 8.00 (2.703%)
Open: 296.00
High: 299.00
Low: 296.00
Prev. Close: 300.00
FSJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full Year Trading Update

8 Feb 2024 07:00

RNS Number : 4068C
Fisher (James) & Sons plc
08 February 2024
 

8 February 2024

James Fisher and Sons plc

Full Year Trading Update

James Fisher and Sons plc (FSJ.L) ('James Fisher', 'the Group') today provides an update on trading for the year ended 31 December 2023, ahead of its Full Year Results.

Overview

Overall underlying trading in the second half was resilient and in line with market expectations. The Group has continued to make further early progress with its transformation during the period, focusing on operational improvements and simplification.

 

Divisional performance

 

Performance trends across all divisions through the second half were generally consistent with the first half. Energy market conditions remained largely supportive, underpinning strong performance in a number of divisional businesses, albeit North Sea IRM (inspection, repair and maintenance) and decommissioning conditions continued to be challenging. While revenue from larger project orders within Defence was lower than anticipated in the year, as procurement timelines were extended by customers, the division retains a solid pipeline and is still expected to deliver an improved year-on-year performance in 2023, underpinned by a focus on efficiency and effectiveness. The Maritime Transport division performed well with Tankships maintaining high tanker utilisation and stable day rates continuing for spot charter while Fendercare benefitted from increased operations in Brazil.

Transformation progress

 

The Group made further strategic progress in the second half to simplify and focus its portfolio, while improving overall financial performance. In December 2023, the Group ceased operations at Subtech Europe, which generated c.£40m of revenue in 2023. This business was incurring losses over a number of years because of increased competition and lower utilisation given the seasonality of the North Sea operations.

Further progress has been made on the Group's transformation projects that will strengthen organisational and operational capabilities. Ongoing costs of restructuring and refinancing together with costs of business closures mean that non-underlying cash costs for the second half are likely to be at a similar level to those reported in H1.

Financial position

 

The Group reduced its borrowings in the second half with pre-IFRS 16 net debt at 31 December 2023 reducing to £140m, from £147m at 30 June 2023 (£133m at 31 December 2022). The increase in net borrowing from 31 December 2022 reflects the additional financing and restructuring costs incurred in the year.

 

Jean Vernet, Chief Executive Officer, commented:

 

"With the steps we have taken to improve our operational and financial performance, I am encouraged by the progress across the three divisions. We are building the foundations for recovery and are seeing the benefits of the operational improvements being implemented. We remain fully committed to our ongoing portfolio simplification, which should further strengthen our balance sheet, as well as the investment in capability that will provide a platform for sustainable growth."

 

- Ends -

 

For further information:

James Fisher and Sons plc

Jean Vernet

Karen Hayzen-Smith

Chief Executive Officer

Chief Financial Officer

020 7614 9503

FTI Consulting

Richard Mountain

Susanne Yule

0203 727 1340

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUGWPUPCGBM
Date   Source Headline
22nd Mar 20224:35 pmRNSHolding(s) in Company
10th Mar 20227:00 amRNSFull year results for the year ended 31 Dec 21
24th Jan 202210:54 amRNSDirector Declaration
29th Dec 20219:55 amRNSMozambique update
17th Dec 20217:00 amRNSAppointment of non-executive director
15th Dec 20215:36 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20215:22 pmRNSHolding(s) in Company
18th Nov 202110:25 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSSale of James Fisher Testing Services for £5.7m
1st Nov 20215:23 pmRNSDirector/PDMR Shareholding
25th Oct 20217:00 amRNSTrading update
22nd Oct 20218:00 amRNSAppointment of non-executive director
15th Sep 20211:26 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf year results for the 6 months ended 30 Jun 21
1st Jul 20217:00 amRNSSale of Paladin for US$17.3m
29th Jun 20217:00 amRNSCapital Markets Event & Pre Close Trading Update
15th Jun 20213:51 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Jun 20214:16 pmRNSDirector/PDMR Shareholding
30th Apr 202111:59 amRNSDirector Declaration
29th Apr 20212:01 pmRNSResult of Annual General Meeting
29th Apr 20217:00 amRNSAGM Trading Statement
20th Apr 20217:00 amRNSAppointment of Chief Financial Officer
13th Apr 202111:32 amRNSWithdrawal of Annual General Meeting Resolution
9th Apr 202110:18 amRNSDirector/PDMR Shareholding
8th Apr 20213:58 pmRNSDirector/PDMR Shareholding
6th Apr 20213:48 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSTotal Voting Rights and Share Capital
29th Mar 20217:00 amRNSDirectorate Change
23rd Mar 202112:58 pmRNSAnnual Report and Notice of AGM posted
19th Mar 20211:17 pmRNSHolding(s) in Company
11th Mar 20217:00 amRNSResults for the year ended 31 December 2020
25th Feb 202110:42 amRNSNotification of FY Results Date
25th Jan 20217:00 amRNSAngus Cockburn appointed as Chairman
7th Jan 20217:00 amRNSPost close trading update
18th Dec 20204:41 pmRNSSecond Price Monitoring Extn
18th Dec 20204:35 pmRNSPrice Monitoring Extension
15th Dec 202011:18 amRNSBLOCK LISTING SIX MONTHLY RETURN
11th Nov 20207:00 amRNSDirector/PDMR Shareholding
9th Nov 20205:25 pmRNSTotal Voting Rights
6th Nov 20207:00 amRNSTrading Update
2nd Nov 20207:00 amRNSTotal Voting Rights
23rd Oct 20209:48 amRNSDirector/PDMR Shareholding
6th Oct 20203:58 pmRNSDirector/PDMR Shareholding
2nd Oct 20207:00 amRNSRoyal Navy contract award
21st Sep 20204:00 pmRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNSHalf-year results
24th Jul 202012:00 pmRNSDirector/PDMR Shareholding
7th Jul 20207:00 amRNSHalf year post close trading update
24th Jun 202012:02 pmRNSPrice Monitoring Extension
15th Jun 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.